Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Hemostasis01:24

Disorders of Hemostasis

2.2K
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.2K
Introduction to Hemostasis01:05

Introduction to Hemostasis

14.1K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
14.1K
Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

12.7K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
12.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Measurement of the charge asymmetry in top quark pair production in <i>pp</i> collisions at [Formula: see text] using the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Search for lepton flavour violation in the <i>eμ</i> continuum with the ATLAS detector in [Formula: see text]<i>pp</i> collisions at the LHC.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of [Formula: see text] production with a veto on additional central jet activity in <i>pp</i> collisions at [Formula: see text] TeV using the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of the top quark mass with the template method in the [Formula: see text] channel using ATLAS data.

The European physical journal. C, Particles and fields·2015
Same author

Search for heavy neutrinos and right-handed <i>W</i> bosons in events with two leptons and jets in <i>pp</i> collisions at [Formula: see text] with the ATLAS detector.

The European physical journal. C, Particles and fields·2015
Same author

Measurement of <i>τ</i> polarization in <i>W</i>→<i>τν</i> decays with the ATLAS detector in <i>pp</i> collisions at [Formula: see text].

The European physical journal. C, Particles and fields·2015
Same journal

Pharmacology of pruritus (pathophysiology, therapeutic targets).

Therapie·2026
Same journal

Barriers to prescribing methylphenidate for adults with ADHD: A qualitative study.

Therapie·2026
Same journal

[Self-medication and its factors amongst Navymen aboard surface ships of the French Navy at sea: A descriptive study].

Therapie·2026
Same journal

Subacute cutaneous lupus erythematosus induced by ticagrelor: Recurrence after rechallenge.

Therapie·2026
Same journal

Multiple HIV virological failures related to bictegravir-valproic acid interaction evidenced by therapeutic drug monitoring: A retrospective study.

Therapie·2026
Same journal

Indication-related misuse of oral fluoroquinolones in adults by general practitioners in France.

Therapie·2026
See all related articles

Related Experiment Video

Updated: Jan 31, 2026

Simple and Effective Procedure for Hemostasis in Mouse Arteries
05:33

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

161

[Prostanoids and hemostasis].

T Lecompte1, S Mamas

  • 1Laboratoire Central d'Hématologie, Hôtel-Dieu, Paris.

Therapie
|May 1, 1991
PubMed
Summary
This summary is machine-generated.

Thromboxane A2 (TXA2) and prostacyclin, key prostanoids, regulate platelet activation. New dual-acting TXA2 agents show promise for anti-thrombotic therapy despite research challenges.

More Related Videos

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.6K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

10.0K

Related Experiment Videos

Last Updated: Jan 31, 2026

Simple and Effective Procedure for Hemostasis in Mouse Arteries
05:33

Simple and Effective Procedure for Hemostasis in Mouse Arteries

Published on: November 28, 2025

161
A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma
04:20

A Saline/Bipolar Radiofrequency Energy Device As an Adjunct for Hemostasis in Solid Organ Injury/Trauma

Published on: July 28, 2020

5.6K
Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro
10:25

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

10.0K

Area of Science:

  • Biochemistry
  • Pharmacology

Context:

  • Prostanoids, Thromboxane A2 (TXA2) and prostacyclin, are derived from arachidonic acid via cyclooxygenase.
  • Aspirin inhibits cyclooxygenase, impacting prostanoid synthesis.
  • Prostanoids are locally acting, short-lived mediators involved in platelet and vascular function.

Purpose:

  • To review the roles of TXA2 and prostacyclin in platelet activation and cardiovascular physiology.
  • To discuss challenges in studying the prostanoid system and their implications for cardiovascular pathology.
  • To evaluate the potential of novel pharmacological agents targeting TXA2.

Summary:

  • Activated platelets synthesize TXA2, promoting further platelet aggregation.
  • Prostacyclin inhibits platelet responses but causes vasodilation.
  • Other inhibitors include PGD2, PGE1, adenosine, and nitric oxide (EDRF), affecting multiple cell types.
  • Analytical difficulties have hindered clinical investigations of the prostanoid system.

Impact:

  • Understanding prostanoid pathways is crucial for cardiovascular health and disease.
  • Novel therapeutics targeting TXA2, such as dual-acting agents, offer potential anti-thrombotic benefits.
  • Further research into selective prostanoid modulation could lead to improved cardiovascular treatments.